Skip to main content

Table 2 Median percent of follow-up time with symptoms per infant

From: Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial

Symptom [Median (SD)]

Control n = 32

Biweekly n = 35

Weekly n = 35

Daily

n = 35

p-value

p-for trend

Diarrhea

0 (2.2)

0 (2.2)

0 (0.5)

0 (1.5)

0.7

0.9

Watery or soft stool

0 (3.8)

0 (7.3)

1.1 (5.5)

1.0 (5.6)

0.3

0.3

Vomiting

0 (3.2)

0 (4.8)

0 (2.9)

0 (2.8)

0.4

0.8

Poor feeding

0 (4.1)

3.3 (8.4)

1.1 (6.6)

2.1 (4.0)

0.8

0.5

Colic

0 (9.0)

0 (6.7)

1.1 (3.0)

1.1 (3.9)

0.5

0.4

Cough

10.0 (17.1)

12.3 (17.1)

14.2 (14.8)

12.8 (12.7)

0.5

0.7

Congestion

9.1 (18.2)

14.8 (17.2)

13.6 (13.0)

15.7 (11.1)

0.4

1.0

Difficulty breathing

0 (4.1)

0 (5.6)

0 (4.5)

0 (1.2)

0.2

0.3

  1. Kruskal-Wallis Test, Test for Linear Trend
  2. Significance for p-values was set at 0.05